Reprieve Cardiovascular
Reprieve Cardiovascular is a Healthcare & Life Sciences startup based in the United States, most recent round Series B, 1 tracked investor.
About Reprieve Cardiovascular
Reprieve Cardiovascular is a company headquartered in the United States. Its most recent tracked round is Series B. Brouky classifies it under Healthcare & Life Sciences. Brouky records 1 investor associated with the company.
Develops the Reprieve System, an intelligent personalized decongestion management solution for patients with acute decompensated heart failure to optimize fluid removal and clinical outcomes. The company is developing a medical device-backed therapy evaluated in randomized clinical trials (FASTR pilot).
Explore Reprieve Cardiovascular's full profile on Brouky
Funding rounds, investor list, risk signals, and comparable startups, all gated to subscribers.